Stock Analysis on Net

Procter & Gamble Co. (NYSE:PG)

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Procter & Gamble Co., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017
Accounts payable 14,234 14,435 14,598 13,790 14,153 14,845 14,882 14,175 14,154 14,223 13,720 12,134 12,027 11,935 12,071 10,464 10,781 10,951 11,260 10,207 10,266 10,243 10,344 9,716 9,740 9,458
Accrued and other liabilities 11,100 10,912 10,929 10,523 10,293 10,056 9,554 10,324 10,542 10,377 10,523 11,109 11,131 10,366 9,722 9,731 10,230 9,950 9,054 9,252 8,868 8,469 7,470 8,133 7,820 7,240
Debt due within one year 10,616 11,811 10,229 13,717 14,300 11,717 8,645 9,902 13,331 11,989 8,889 8,773 8,586 7,707 11,183 12,701 9,153 9,352 9,697 8,911 12,113 10,508 10,423 12,862 15,547 14,026
Current liabilities 35,950 37,158 35,756 38,030 38,746 36,618 33,081 34,401 38,027 36,589 33,132 32,016 31,744 30,008 32,976 32,896 30,164 30,253 30,011 28,370 31,247 29,220 28,237 30,711 33,107 30,724
Long-term debt, excluding due within one year 23,096 24,069 24,378 22,874 20,582 21,286 22,848 23,767 22,322 20,558 23,099 21,053 22,514 23,948 23,537 23,310 18,985 20,161 20,395 21,359 21,514 20,779 20,863 22,437 22,186 20,188
Deferred income taxes 6,219 6,814 6,478 6,422 6,462 6,986 6,809 6,543 6,506 6,323 6,153 5,977 6,073 6,294 6,199 6,309 6,242 6,325 6,899 6,951 6,872 6,179 6,163 6,083 6,145 8,481
Other noncurrent liabilities 6,615 6,476 7,152 7,104 7,200 7,058 7,616 9,760 9,668 9,791 10,269 10,813 11,241 11,073 11,110 10,104 10,424 10,335 10,211 9,441 9,611 9,758 10,164 10,192 10,485 8,043
Noncurrent liabilities 35,930 37,359 38,008 36,400 34,244 35,330 37,273 40,070 38,496 36,672 39,521 37,843 39,828 41,315 40,846 39,723 35,651 36,821 37,505 37,751 37,997 36,716 37,190 38,712 38,816 36,712
Total liabilities 71,880 74,517 73,764 74,430 72,990 71,948 70,354 74,471 76,523 73,261 72,653 69,859 71,572 71,323 73,822 72,619 65,815 67,074 67,516 66,121 69,244 65,936 65,427 69,423 71,923 67,436
Preferred stock 809 812 819 822 831 834 843 846 856 859 870 873 885 888 897 900 911 915 928 933 946 951 967 972 986 991
Common stock 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009 4,009
Additional paid-in capital 66,935 66,822 66,556 66,316 66,145 65,955 65,795 65,614 65,432 65,148 64,848 64,682 64,672 64,467 64,194 63,976 64,019 63,949 63,827 63,624 63,679 63,711 63,846 63,717 63,757 63,705
Reserve for ESOP debt retirement (782) (782) (821) (821) (870) (870) (916) (916) (965) (964) (1,006) (1,006) (1,072) (1,046) (1,080) (1,080) (1,112) (1,112) (1,146) (1,145) (1,178) (1,177) (1,204) (1,203) (1,229) (1,229)
Accumulated other comprehensive loss (12,167) (12,583) (12,220) (12,266) (12,506) (12,811) (12,189) (13,448) (13,564) (14,062) (13,744) (15,489) (15,091) (15,881) (16,165) (15,916) (14,942) (15,298) (14,936) (14,968) (15,156) (15,133) (14,749) (13,891) (14,171) (14,292)
Treasury stock (131,886) (131,028) (129,736) (130,002) (129,012) (127,205) (123,382) (122,272) (121,543) (117,240) (114,973) (112,147) (109,583) (106,794) (105,573) (105,823) (105,761) (102,510) (100,406) (99,484) (99,480) (99,956) (99,217) (97,912) (97,121) (95,563)
Retained earnings 121,617 120,443 118,170 117,082 115,858 114,163 112,429 111,645 110,393 108,361 106,374 105,674 104,361 102,539 100,239 99,474 98,414 96,625 94,918 102,103 101,170 99,831 98,641 98,623 97,881 97,197
Shareholders’ equity attributable to Procter & Gamble 48,535 47,693 46,777 45,140 44,455 44,075 46,589 45,478 44,618 46,111 46,378 46,596 48,181 48,182 46,521 45,540 45,538 46,578 47,194 55,072 53,990 52,236 52,293 54,315 54,112 54,818
Noncontrolling interest 294 321 288 281 270 259 265 268 275 297 276 323 359 394 357 401 370 406 385 480 453 268 590 631 609 597
Total shareholders’ equity 48,829 48,014 47,065 45,421 44,725 44,334 46,854 45,746 44,893 46,408 46,654 46,919 48,540 48,576 46,878 45,941 45,908 46,984 47,579 55,552 54,443 52,504 52,883 54,946 54,721 55,415
Total liabilities and shareholders’ equity 120,709 122,531 120,829 119,851 117,715 116,282 117,208 120,217 121,416 119,669 119,307 116,778 120,112 119,899 120,700 118,560 111,723 114,058 115,095 121,673 123,687 118,440 118,310 124,369 126,644 122,851

Based on: 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-K (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-K (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-K (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-K (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-K (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-K (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Procter & Gamble Co. current liabilities increased from Q4 2023 to Q1 2024 but then slightly decreased from Q1 2024 to Q2 2024 not reaching Q4 2023 level.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Procter & Gamble Co. noncurrent liabilities decreased from Q4 2023 to Q1 2024 and from Q1 2024 to Q2 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Procter & Gamble Co. total liabilities increased from Q4 2023 to Q1 2024 but then decreased significantly from Q1 2024 to Q2 2024.
Shareholders’ equity attributable to Procter & Gamble Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Procter & Gamble Co. shareholders’ equity attributable to Procter & Gamble increased from Q4 2023 to Q1 2024 and from Q1 2024 to Q2 2024.